Loading
AP
Advanced Proteome Therapeutics Corporation Stock: price and insider trades · Canada
Advanced Proteome Therapeutics Corporation: what insiders have been doing
Advanced Proteome Therapeutics Corporation is a listed company. Its directors and officers file their transactions with SEDI. The past year has been quiet: not a single insider filing for Advanced Proteome Therapeutics Corporation. The previous disclosure was published on 23 December 2022.
The full history, which starts in 2016, counts 10 purchases against 20 sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
68
Thresholds
n/a
Buy Volume
€7,907
10 ops. · all time
Sell Volume
€53,160
20 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 23 December 2022
Declarations68 total
1,450,000 shares@ CA$0.05Common SharesTSXSEDI:4050078
16,000 shares@ CA$0.035Common SharesTSXSEDI:4049292
Canonical exit: 22 Mar 2023 (T+90)
18,000 shares@ CA$0.035Common SharesTSXSEDI:4048505
Canonical exit: 21 Mar 2023 (T+90)
15,000 shares@ CA$0.03Common SharesTSXSEDI:4045043
Canonical exit: 15 Mar 2023 (T+90)
1,000 shares@ CA$0.110.1% of flowCommon SharesTSXSEDI:3950526
Canonical exit: 23 Aug 2022 (T+90)
8,000 shares@ CA$0.110.5% of flowCommon SharesTSXSEDI:3949438
Canonical exit: 18 Aug 2022 (T+90)
20,000 shares@ CA$0.1351.6% of flowCommon SharesTSXSEDI:3878255
Canonical exit: 3 May 2022 (T+90)
100,000 shares@ CA$0.0638.8% of flowCommon SharesTSXSEDI:3875535
250,000 shares@ CA$0.10100.0% of flowCommon SharesTSXSEDI:3834850
500 shares@ CA$0.400.1% of flowCommon SharesTSXSEDI:3727500
49,500 shares@ CA$0.3713.5% of flowCommon SharesTSXSEDI:3727501
140,000 shares@ CA$0.1010.3% of flowCommon SharesTSXSEDI:3703207
270,000 shares@ CA$0.1019.5% of flowCommon SharesTSXSEDI:3686051
15,000 shares@ CA$0.212.3% of flowCommon SharesTSXSEDI:3686034
25,000 shares@ CA$0.244.3% of flowCommon SharesTSXSEDI:3686038
20,000 shares@ CA$0.2253.3% of flowCommon SharesTSXSEDI:3686037
25,000 shares@ CA$0.254.5% of flowCommon SharesTSXSEDI:3686040
2,000 shares@ CA$0.300.4% of flowCommon SharesTSXSEDI:3686043
34,500 shares@ CA$0.1853.6% of flowCommon SharesTSXSEDI:3683286
25,000 shares@ CA$0.202.8% of flowCommon SharesTSXSEDI:3683287
2,000 shares@ CA$0.1550.2% of flowCommon SharesTSXSEDI:3681201
25,000 shares@ CA$0.1552.2% of flowCommon SharesTSXSEDI:3681203
20,000 shares@ CA$0.151.7% of flowCommon SharesTSXSEDI:3681206
50,000 shares@ CA$0.1454.0% of flowCommon SharesTSXSEDI:3677846
140,000 shares@ CA$0.107.7% of flowCommon SharesTSXSEDI:3669626
25 of 68 declarations
About Advanced Proteome Therapeutics Corporation
Advanced Proteome Therapeutics Corporation is a company focused on developing protein-based therapies. It is listed on the XTSE market.
